Study With a Topical Gel to Treat Common Warts in Adults

Phase 2

Completed

• Conditions: Warts

• Registration Number: NCT00117923
• Lead Sponsor: Graceway Pharmaceuticals, LLC

Brief Summary

The primary purpose of this study is to evaluate the effectiveness in adults of four different strengths of resiquimod gel applied to common wart(s) five times a week for four weeks.

A second purpose is to evaluate the safety of the drug.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-08
• Study First Submitted: 2005-06-30
• Study First Submitted QC: 2005-06-30
• Study First Posted: 2005-07-11
• Status Verified: 2006-11
• Last Update Submitted: 2007-02-16
• Last Update Posted: 2007-02-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

• Diagnosis of common warts
• Two forms of birth control

Exclusion Criteria

• Pregnant or breast feeding
• Other types of warts, ie. plantar
• Currently participating in another clinical study
• Chronic viral hepatitis B or C

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Clearance of treated wart(s)

Secondary Outcome Measures

Name	Time	Method
Partial clearance of treated wart(s)
Wart recurrence

Trial Locations

Locations (1)

Oregon Medical Research Center; 🇺🇸 Portland, Oregon, United States